Measles confirmed in Broward child under 4 in April, officials say
There was one case of measles in Broward County in April, according to state records, at the same time a link to those records was briefly removed from the state website.
A child between the age of 0 (used to refer to newborns) and 4 contracted measles from outside of the U.S. in April in Broward County, according to the Florida Department of Health (DOH) Reportable Disease Frequency Report.
Measles is considered one of the most contagious infections for humans, according to Dr. Aileen Marty, a professor at Florida International University and an expert in infectious disease and disaster medicine. If a person with measles comes in contact with a group of unvaccinated people, there is a 90% chance of the unvaccinated person becoming ill, according to the National Foundation for Infectious Diseases.
A link to the state report, which tracks the spread of infectious diseases across the state's 67 counties, was removed from DOH's main website earlier this year, according to a story in the South Florida Sun Sentinel. According to the article, published on May 9, the last time that chart was available was in March.
The website was getting upgraded at the time, DOH spokesperson Isabel Kilman told the USA TODAY Network – Florida.
But now, the tracker, which can be found as a link on the FLHealthCHARTS website, shows a measles case in Broward County in April.
It occurred one month after a high schooler at Miami Palmetto Senior High School in Miami-Dade County was diagnosed with the highly-contagious disease.
There are no alerts on the the Florida Department of Health in Broward County website or the state DOH website about the measles case in April.
Kilman could not confirm to a USA TODAY Network – Florida reporter that the department did contact tracing with the case in Broward County, but did say if its epidemiologists had a reason to believe people came in contact with someone with measles, they would be notified.
Contact tracing is the process of identifying people who have recently been in contact with someone diagnosed with an infectious disease, according to the U.S. Centers for Disease Control.
In a statement sent by email, DOH said it could not disclose personal information about the case because of the Health Insurance Portability and Accountability Act, or HIPAA. It establishes federal standards protecting sensitive health information from disclosure without patient's consent, according to the CDC.
"The Department works closely with schools and school systems to ensure that students, faculty, and parents are informed when appropriate. Anyone who may have been in contact with an infected individual is promptly and directly notified to ensure the safety and well-being of the community," the statement says.
The exact age of the child is unknown, as the state's data provides a range from 0 to 4 years old. But a spokesperson for Broward County Schools said the district's Coordinated Student Health Services Department reported it has not had a documented case of measles this year.
Last year, the county saw a measles outbreak that resulted in nine infections. DOH's response at the time was criticized after Florida Surgeon General Joseph Ladapo contradicted federal and medical professional guidance to contain the spread.
As previously reported, measles infections in the U.S. have topped 1,000 in 2025. While Texas remains the epicenter battling the largest number of cases, the presence of measles has been confirmed in 30 states by the Centers for Disease Control (CDC) as of Friday, March 9.
Recently, a person infected measles may have spread the virus at a Shakira concert in New Jersey, according to news reports.
According to the U.S. Centers for Disease Control, only 88.1% of kindergarteners in Florida were vaccinated against measles in 2023-2024. Herd immunity for measles requires a 95% vaccination rate.
Whether someone gets measles are a child or as an adult, it affects the body's immune response, Marty said. Measles can cause viral pneumonia or in some cases bacterial pnuemonia, because it diminishes the immune system.
It's rare, but some children that contract measles will, years later, manifest serious neurologic problems, she added.
"If you look at what's been going on in the United States, for example ... We won't know the total toll of that outbreak for six to 10 years because of this sort of under-the-radar type of problem that manifests so much later," she said.
Ana Goñi-Lessan, state watchdog reporter for the USA TODAY Network – Florida, can be reached at agonilessan@gannett.com.
This article originally appeared on Tallahassee Democrat: Broward measles case in April adds to growing national resurgence
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 hours ago
- Yahoo
Kauaʻi to survey community for emergency preparedness
LIHUE, Hawaii (KHON2) — The Hawaiʻi Department of Health's Kauaʻi District Health Office will be conducting a Community Assessment for Public Health Emergency Response, also known as a CASPER survey, this month to assess the preparedness of the island's community. From June 23 to June 27, survey teams will canvas 30 randomly selected blocks in the island, with seven houses from each block will also be systematically selected and surveyed. Wanted man arrested after 'crime spree' leads to officer-involved shooting Households will be asked about their plans should an emergency occur or evacuations be necessary, in regards to any climate issues, disease issues and general day-to-day Kauaʻi topics. 'By asking households about their emergency supplies and evacuation plans, CASPER surveys enable the Kauaʻi District Health Office and the county to better meet our community's needs before, during and after a disaster,' said Lauren Guest, a deputy district health officer from the Kauaʻi Epidemiology and Laboratory Capacity also added that the surveys help emergency response staff train in the field prior to a local disaster. Survey teams will be made up of DOH staff, Kauaʻi Medical Reserve Corps and the Kauaʻi Emergency Management Agency. The survey will take approximately 10 minutes to complete, and participation is voluntary. Responses are completely confidential. This will mark the eighth CASPER survey on the island. For prior survey reports, visit DOH's website. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.


Business Upturn
9 hours ago
- Business Upturn
ByteBrain Launches MEDRAIL: AI System to Accelerate and Safeguard Clinical Trials
Sheridan, Wyoming, June 05, 2025 (GLOBE NEWSWIRE) — ByteBrain LLC, an emerging AI research and consulting firm , has announced the launch of MEDRAIL, an intelligent platform designed to help pharmaceutical companies run faster, safer, and more adaptive clinical trials. ByteBrain MEDRAIL, short for MEDical Reinforcement-based Agentic Intelligence for Lifesciences, brings together the power of artificial intelligence and advanced compliance automation to modernize the clinical trial process. The company has filed for a U.S. patent under the USPTO's Track One program to fast-track protection of the platform's novel technology. Priyanshu Sharma, co-founder of ByteBrain 'Clinical trials are often slow, costly, and difficult to manage, especially in fast-evolving medical landscapes,' said Priyanshu Sharma, Co-Founder of ByteBrain. 'MEDRAIL helps organizations react to safety data faster, reduce manual errors, and stay compliant with global regulatory standards.' A Smarter Way to Run Clinical Trials MEDRAIL uses a team of specialized AI agents, each trained to handle tasks like patient recruitment, protocol monitoring, safety surveillance, and documentation compliance. These agents work together in real time, adjusting to trial data and new regulatory guidelines as they emerge. Priyanshi Bhatnagar, co-founder of ByteBrain 'What makes MEDRAIL unique is its built-in safety verification and explainability,' added Priyanshi Bhatnagar, Co-Founder. 'Every protocol change, every recommendation, it's backed by formal logic, transparent reasoning, and a full audit trail.' Key Benefits of MEDRAIL: Faster protocol design and amendments Early detection of safety issues using AI Built-in compliance with FDA, HIPAA, and ICH-GCP standards Automated documentation with complete audit logs Seamless integration with existing clinical workflows Why It Matters Clinical trials can cost up to $3 billion per approved drug and take more than a decade to complete. ByteBrain believes that smarter, AI-assisted trial systems can cut that time significantly, potentially saving millions and accelerating time-to-market for life-saving therapies. The platform was developed with input from clinical research experts across pharma, academic medical centers, and regulatory affairs. Initial feedback has been positive, with ByteBrain preparing to release technical papers and pilot studies in the coming months. About ByteBrain ByteBrain LLC is a research-first AI company specializing in complex, regulated industries . Based in the U.S., it combines consulting services with the development of advanced IP in healthcare, finance, and enterprise AI systems. MEDRAIL is the firm's flagship healthtech innovation and part of its broader mission to build human-centered, compliance-ready AI solutions. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Yahoo
12 hours ago
- Yahoo
ByteBrain Launches MEDRAIL: AI System to Accelerate and Safeguard Clinical Trials
ByteBrain launches MEDRAIL, an AI-powered platform designed to support faster, safer, and more compliant clinical trials across the pharmaceutical industry Sheridan, Wyoming, June 05, 2025 (GLOBE NEWSWIRE) -- ByteBrain LLC, an emerging AI research and consulting firm, has announced the launch of MEDRAIL, an intelligent platform designed to help pharmaceutical companies run faster, safer, and more adaptive clinical trials. ByteBrain MEDRAIL, short for MEDical Reinforcement-based Agentic Intelligence for Lifesciences, brings together the power of artificial intelligence and advanced compliance automation to modernize the clinical trial process. The company has filed for a U.S. patent under the USPTO's Track One program to fast-track protection of the platform's novel technology. Priyanshu Sharma, co-founder of ByteBrain 'Clinical trials are often slow, costly, and difficult to manage, especially in fast-evolving medical landscapes,' said Priyanshu Sharma, Co-Founder of ByteBrain. 'MEDRAIL helps organizations react to safety data faster, reduce manual errors, and stay compliant with global regulatory standards.' A Smarter Way to Run Clinical Trials MEDRAIL uses a team of specialized AI agents, each trained to handle tasks like patient recruitment, protocol monitoring, safety surveillance, and documentation compliance. These agents work together in real time, adjusting to trial data and new regulatory guidelines as they emerge. Priyanshi Bhatnagar, co-founder of ByteBrain 'What makes MEDRAIL unique is its built-in safety verification and explainability,' added Priyanshi Bhatnagar, Co-Founder. 'Every protocol change, every recommendation, it's backed by formal logic, transparent reasoning, and a full audit trail.' Key Benefits of MEDRAIL: Faster protocol design and amendments Early detection of safety issues using AI Built-in compliance with FDA, HIPAA, and ICH-GCP standards Automated documentation with complete audit logs Seamless integration with existing clinical workflows Why It Matters Clinical trials can cost up to $3 billion per approved drug and take more than a decade to complete. ByteBrain believes that smarter, AI-assisted trial systems can cut that time significantly, potentially saving millions and accelerating time-to-market for life-saving therapies. The platform was developed with input from clinical research experts across pharma, academic medical centers, and regulatory affairs. Initial feedback has been positive, with ByteBrain preparing to release technical papers and pilot studies in the coming months. About ByteBrain ByteBrain LLC is a research-first AI company specializing in complex, regulated industries. Based in the U.S., it combines consulting services with the development of advanced IP in healthcare, finance, and enterprise AI systems. MEDRAIL is the firm's flagship healthtech innovation and part of its broader mission to build human-centered, compliance-ready AI solutions. CONTACT: Priyanshu Sharma | ByteBrain contact@ lors de la récupération des données Connectez-vous pour accéder à votre portefeuille Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données